XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Balance Sheet Account Detail
 6 Months Ended
Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Account Detail BALANCE SHEET ACCOUNT DETAIL
The composition of selected financial statement captions that comprise the accompanying balance sheets are summarized below:
(a) Property and Equipment, net of Accumulated Depreciation
“Property and equipment, net of accumulated depreciation” consists of the following:
June 30, 2021December 31, 2020
Furniture and fixtures$365 $294 
Office equipment52 74 
Lab equipment167 173 
Leasehold improvements163 141 
Property and equipment, at cost747 682 
(Less): Accumulated depreciation and amortization266 134 
Property and equipment, net of accumulated depreciation and amortization$481 $548 
Depreciation expense (included within “total operating expenses” in the accompanying Statements of Operations and Comprehensive Income (Loss)) for the three months ended June 30, 2021 and 2020 was $125 thousand and $17 thousand, respectively, and for the six months ended June 30, 2021 and 2020 was $189 thousand and $32 thousand, respectively.
(b) Other Assets
"Other assets" consists of the following:
June 30, 2021December 31, 2020
Deposits$27 $33 
Equity warrant rights*1,076 — 
Other long term assets422 48 
Other assets$1,525 $81 
*In January 2020, the FASB issued Accounting Standards Update No. 2020-01, Investments—Equity Securities (Topic 321),      Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force), which clarifies the interaction of the accounting for equity securities, investments accounted for under the equity method, and certain forward contracts and purchased options. This update is effective for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The Company is in the process of determining the impact the adoption will have on its financial statements, beginning as of and for the three months ending March 31, 2022.
(c) Accounts Payable and Other Accrued Liabilities 
“Accounts payable and other accrued liabilities” consists of the following:
June 30, 2021December 31, 2020
Trade accounts payable and other$3,303 $2,237 
Operating lease liability, current portion229 282 
Accrued clinical studies3,358 1,524 
Contract liability1,504 — 
Income taxes payable342 — 
Employee stock option early exercise liability, current portion249 304 
Accounts payable and other accrued liabilities$8,985 $4,347 
(d) Other Long-Term Liabilities
“Other long-term liabilities” consists of the following:
June 30, 2021December 31, 2020
Operating lease liability, non-current portion$405 $549 
Derivative liability107 — 
Employee stock option early exercise liability, non-current portion12 56 
Other long-term liabilities$524 $605